A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called ErbB-2 and EGFR dual kinase inhibitors.
Selected GW572016 links:
|© 1997-2005 Healthboard.com. Healthboard.com is a purely informational website, and should not be used as a substitute for professional legal, medical or technical advice.|